Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma
Johanna Gebhart(Medical University of Vienna), Katharina Geißler(Jena University Hospital), Peter Quehenberger, Thamer Sliwa(Hanusch Hospital), Ulrich Jäger(Medical University of Vienna), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Katrina Vanura(Comprehensive Cancer Center Vienna), Thomas Nösslinger(Hanusch Hospital), Ingrid Simonitsch‐Klupp(Medical University of Vienna), Cathrin Skrabs(Medical University of Vienna), Gerlinde Mitterbauer‐Hohendanner(Medical University of Vienna), H. Ludwig(Universitätsmedizin Göttingen), Klaus Lechner, Ercan Müldür(Wilhelminen Hospital), Andreas Chott(University of Vienna), Ingrid Pabinger(Medical University of Vienna)
Cited by 25
Related Papers
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425